Clorox (NYSE:CLX) PT Raised to $137.00 at Barclays

Clorox (NYSE:CLX) had its price objective lifted by research analysts at Barclays from $130.00 to $137.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s price target would indicate a potential downside of 14.20% from the company’s current price.

Several other research analysts have also recently weighed in on CLX. DA Davidson reissued a “neutral” rating and set a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. Wells Fargo & Company decreased their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday. Finally, BNP Paribas raised shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Six analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $148.33.

Clorox Stock Up 1.0 %

Clorox stock traded up $1.63 during trading hours on Friday, hitting $159.68. The stock had a trading volume of 83,674 shares, compared to its average volume of 1,236,916. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The stock has a market capitalization of $19.78 billion, a P/E ratio of 71.25, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. Clorox has a 12-month low of $114.68 and a 12-month high of $169.09. The stock’s 50-day moving average price is $157.03 and its 200-day moving average price is $144.74.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Equities research analysts anticipate that Clorox will post 6.64 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.51% of the stock is owned by company insiders.

Hedge Funds Weigh In On Clorox

A number of hedge funds and other institutional investors have recently modified their holdings of CLX. V Square Quantitative Management LLC boosted its position in shares of Clorox by 128.3% during the fourth quarter. V Square Quantitative Management LLC now owns 4,629 shares of the company’s stock worth $660,000 after acquiring an additional 2,601 shares during the last quarter. Integrated Advisors Network LLC raised its stake in Clorox by 15.1% during the fourth quarter. Integrated Advisors Network LLC now owns 3,338 shares of the company’s stock valued at $476,000 after purchasing an additional 437 shares in the last quarter. Syon Capital LLC purchased a new stake in Clorox during the fourth quarter valued at $284,000. EP Wealth Advisors LLC raised its stake in Clorox by 4.0% during the fourth quarter. EP Wealth Advisors LLC now owns 6,810 shares of the company’s stock valued at $971,000 after purchasing an additional 263 shares in the last quarter. Finally, Richardson Financial Services Inc. purchased a new stake in Clorox during the fourth quarter valued at $51,000. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.